Effective February 14, 2017, BC Pharmacare has approved innohep for the additional indication of CAT for up to 6 months. For more information, please click here.
Effective February 14, 2017, BC Pharmacare has approved innohep for the additional indication of CAT for up to 6 months. For more information, please click here.